|
CN111088284A
|
|
AAV vector carrying truncated dystrophin gene expression frame, preparation method and application
|
|
CN111088264A
|
|
Adeno-associated virus vector carrying C3 gene expression cassette and application thereof
|
|
CN111084888A
|
|
Gene medicine for treating severe hypertriglyceridemia
|
|
CN111088268A
|
|
Gene therapy medicine for hyperuricemia
|
|
CN109207520A
|
|
The genomic medicine of Leber hereditary optic neuropathy
|
|
CN108588097A
|
|
Improved HBV gene group and compositions related and its application
|
|
CN106884014A
|
|
Adeno-associated virus inverted terminal repeat mutant and its application
|
|
CN103014064A
|
|
Construction and application of AAV vector with ITRs arranged co-directionally
|
|
CN103014055A
|
|
Construction and application of eukaryotic expression vector carrying double-screening genes
|
|
CN102719556A
|
|
AAV vector-based high-throughput miRNA activity detection method, and applications thereof
|
|
CN102311974A
|
|
Recombinant adeno-associated virus-hepatitis B virus 1.3 (rAAV8-HBV1.3) for establishing HBV mouse model
|
|
CN102311973A
|
|
Novel co-expression vector for micro ribonucleic acids (miRNAs) and coding protein genes
|
